Kovai Medical Center & Hospital has again marked its eminent presence in its Orbital territory by adapting the art of latest technologies in life extending treatments.
Coimbatore, today received Research Scientist and Nuclear Medicine Doctors & Physicist scholars from Austria, Australia, Belgium, Canada, Germany, Poland, Qatar, Russia & Srilankan to acquire and to share knowledge from KMCH Nuclear Medicine Department.
Yes! Nuclear medicine when it is been used with perfect combination and strong boundaries it remains a wise option for novel treatment.
Advanced liver cancers, which cannot be cured, but need palliation for better quality of life, are being treated by radionuclide therapy using radio conjugates. Nuclear medicine specialists are doctors who help this kind of patients with this novel and advanced treatment option. Having said that, these options are very expensive and is thus out of reach of economically deprived patients in countries like India. To enable our patients to have these options, but at an affordable price, we need cheaper and better alternatives.
The Nuclear medicine department of Kovai Medical Center Hospital, in Coimbatore has done exactly that by being at the forefront of making available a novel treatment option called Rhenium 188 Lipiodol which is used for liver cancer treatment. This radio conjugate is cheaper and equally effective if not better than other available options in treating advanced liver cancers. This department headed by nuclear medicine specialist Dr Ajit Shinto has been spearheading this treatment modalities since 2015 and is are now considered as one of the leading centers in the world that offers this treatment option.
To enable this technology (Rhenium 188 Lipiodol) to reach a wider group of patients around the world, KMCH had hosted the 2nd World Rhenium Congress on the 14th of August, 2017. This unique conference was a platform to aid training and foster research collaborations between faculty and participants from about 22 countries around the globe, making it as a one of its best kind of event.
Speaking at the event, KMCH Chairman, said that KMCH has always been ahead & stood forefront in embracing the novel treatment option that has been applied & adapted to treat a deadly cancer like Liver cancer. He reinstated that KMCH is proud to support any effort been taken to spread the availability of low cost, highly effective therapies such as Rhenium, as that is need of the hour in countries like ours.
Hon'ble Deputy Minister of Health, Srilanka Mr.Faial Cassim who was the chief guest, expressed his desire to make such advanced treatment facilities made available in his country and requested expertise, training and manpower from KMCH and its other institutions to help in his vision come true. Mr.D.K.Shukla, Executive Director AERB, expounded that with strong framework and regulations in the field of radio radionuclide therapy, an enormous volume of patient community could be benefited by setting up similar therapy facilities across the country. Dr.Mathew Cherian, Chief of Radiology services at KMCH, stressed on the need to spread the technology to centers across India and the world so more and more patients would may be benefited.
The conference was graced by about 250 nuclear medicine scientists and technologists from across the globe. By organizing this International congress KMCH has again proved its existence in the Global market.
Coimbatore, today received Research Scientist and Nuclear Medicine Doctors & Physicist scholars from Austria, Australia, Belgium, Canada, Germany, Poland, Qatar, Russia & Srilankan to acquire and to share knowledge from KMCH Nuclear Medicine Department.
Yes! Nuclear medicine when it is been used with perfect combination and strong boundaries it remains a wise option for novel treatment.
Advanced liver cancers, which cannot be cured, but need palliation for better quality of life, are being treated by radionuclide therapy using radio conjugates. Nuclear medicine specialists are doctors who help this kind of patients with this novel and advanced treatment option. Having said that, these options are very expensive and is thus out of reach of economically deprived patients in countries like India. To enable our patients to have these options, but at an affordable price, we need cheaper and better alternatives.
The Nuclear medicine department of Kovai Medical Center Hospital, in Coimbatore has done exactly that by being at the forefront of making available a novel treatment option called Rhenium 188 Lipiodol which is used for liver cancer treatment. This radio conjugate is cheaper and equally effective if not better than other available options in treating advanced liver cancers. This department headed by nuclear medicine specialist Dr Ajit Shinto has been spearheading this treatment modalities since 2015 and is are now considered as one of the leading centers in the world that offers this treatment option.
To enable this technology (Rhenium 188 Lipiodol) to reach a wider group of patients around the world, KMCH had hosted the 2nd World Rhenium Congress on the 14th of August, 2017. This unique conference was a platform to aid training and foster research collaborations between faculty and participants from about 22 countries around the globe, making it as a one of its best kind of event.
Speaking at the event, KMCH Chairman, said that KMCH has always been ahead & stood forefront in embracing the novel treatment option that has been applied & adapted to treat a deadly cancer like Liver cancer. He reinstated that KMCH is proud to support any effort been taken to spread the availability of low cost, highly effective therapies such as Rhenium, as that is need of the hour in countries like ours.
Hon'ble Deputy Minister of Health, Srilanka Mr.Faial Cassim who was the chief guest, expressed his desire to make such advanced treatment facilities made available in his country and requested expertise, training and manpower from KMCH and its other institutions to help in his vision come true. Mr.D.K.Shukla, Executive Director AERB, expounded that with strong framework and regulations in the field of radio radionuclide therapy, an enormous volume of patient community could be benefited by setting up similar therapy facilities across the country. Dr.Mathew Cherian, Chief of Radiology services at KMCH, stressed on the need to spread the technology to centers across India and the world so more and more patients would may be benefited.
The conference was graced by about 250 nuclear medicine scientists and technologists from across the globe. By organizing this International congress KMCH has again proved its existence in the Global market.